NT-proBNP Mediates the Association Between FGF23 and All-Cause Mortality in Individuals With Type 2 Diabetes

被引:0
作者
van der Vaart, Amarens [1 ,2 ,3 ]
Bakker, Stephan J. L. [2 ]
Laverman, Gozewijn D. [4 ]
van Dijk, Peter R. [3 ]
de Borst, Martin H. [2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, POB 30-001, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Endocrinol, Groningen, Netherlands
[4] Ziekenhuisgrp Twente, Div Nephrol, Dept Internal Med, Hengelo, Netherlands
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 23期
关键词
FGF23; NT-proBNP; type; 2; diabetes; volume homeostasis; GROWTH-FACTOR; 23; HEART; FGF-23;
D O I
10.1161/JAHA.123.031873
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: FGF23 (fibroblast growth factor 23) is associated with a higher mortality risk in type 2 diabetes, but the mechanism is unclear. We aimed to study whether NT-proBNP (N-terminal pro-brain natriuretic peptide) mediates the association between FGF23 and mortality.Methods and results: We analyzed C-terminal FGF23 and NT-proBNP levels in 399 patients with type 2 diabetes. Cox regression analyses were performed, followed by mediation analyses using Structural Equation Modeling. During follow-up of 9.2 [7.6-11.3] years, 117 individuals died. FGF23 was associated with all-cause mortality, independent of potential confounders (fully adjusted hazard ratio [HR], 2.32 [95% CI, 1.21-4.43], P=0.01). The association was lost upon further adjustment for NT-proBNP (HR, 1.84; 95% CI, 0.91-3.73). NT-proBNP accounted for 26% of the mediation effect between FGF23 and all-cause mortality.Conclusions: These findings suggest that a higher FGF23 level is associated with increased mortality in individuals with type 2 diabetes through an effect on volume homeostasis.
引用
收藏
页数:5
相关论文
共 18 条
  • [1] FGF23 regulates renal sodium handling and blood pressure
    Andrukhova, Olena
    Slavic, Svetlana
    Smorodchenko, Alina
    Zeitz, Ute
    Shalhoub, Victoria
    Lanske, Beate
    Pohl, Elena E.
    Erben, Reinhold G.
    [J]. EMBO MOLECULAR MEDICINE, 2014, 6 (06) : 744 - 759
  • [2] FGF23 promotes renal calcium reabsorption through the TRPV5 channel
    Andrukhova, Olena
    Smorodchenko, Alina
    Egerbacher, Monika
    Streicher, Carmen
    Zeitz, Ute
    Goetz, Regina
    Shalhoub, Victoria
    Mohammadi, Moosa
    Pohl, Elena E.
    Lanske, Beate
    Erben, Reinhold G.
    [J]. EMBO JOURNAL, 2014, 33 (03) : 229 - 246
  • [3] Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
    Baia, Leandro C.
    Humalda, Jelmer K.
    Vervloet, Marc G.
    Navis, Gerjan
    Bakker, Stephan J. L.
    de Borst, Martin H.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (11): : 1968 - 1978
  • [4] Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
    Cornelissen, Anne
    Florescu, Roberta
    Kneizeh, Kinan
    Cornelissen, Christian
    Brandenburg, Vincent
    Liehn, Elisa
    Schuh, Alexander
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
    De Jong, Maarten A.
    Eisenga, Michele F.
    van Ballegooijen, Adriana J.
    Beulens, Joline W. J.
    Vervloet, Marc G.
    Navis, Gerjan
    Gansevoort, Ron T.
    Bakker, Stephan J. L.
    De Borst, Martin H.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (01) : 121 - 128
  • [6] FGF23 induces left ventricular hypertrophy
    Faul, Christian
    Amaral, Ansel P.
    Oskouei, Behzad
    Hu, Ming-Chang
    Sloan, Alexis
    Isakova, Tamara
    Gutierrez, Orlando M.
    Aguillon-Prada, Robier
    Lincoln, Joy
    Hare, Joshua M.
    Mundel, Peter
    Morales, Azorides
    Scialla, Julia
    Fischer, Michael
    Soliman, Elsayed Z.
    Chen, Jing
    Go, Alan S.
    Rosas, Sylvia E.
    Nessel, Lisa
    Townsend, Raymond R.
    Feldman, Harold I.
    Sutton, Martin St. John
    Ojo, Akinlolu
    Gadegbeku, Crystal
    Di Marco, Giovana Seno
    Reuter, Stefan
    Kentrup, Dominik
    Tiemann, Klaus
    Brand, Marcus
    Hill, Joseph A.
    Moe, Orson W.
    Kuro-o, Makoto
    Kusek, John W.
    Keane, Martin G.
    Wolf, Myles
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (11) : 4393 - 4408
  • [7] Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
    Gant, Christina M.
    Binnenmars, S. Heleen
    van den Berg, Else
    Bakker, Stephan J. L.
    Navis, Gerjan
    Laverman, Gozewijn D.
    [J]. NUTRIENTS, 2017, 9 (07)
  • [8] Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy
    Humalda, Jelmer K.
    Seiler-Mussler, Sarah
    Kwakernaak, Arjan J.
    Vervloet, Marc G.
    Navis, Gerjan
    Fliser, Danilo
    Heine, Gunnar H.
    de Borst, Martin H.
    [J]. MEDICINE, 2016, 95 (46)
  • [9] DIABETES AND CARDIOVASCULAR-DISEASE - FRAMINGHAM-STUDY
    KANNEL, WB
    MCGEE, DL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (19): : 2035 - 2038
  • [10] Diabetes Mellitus Is an Independent Predictor for the Development of Heart Failure: A Population Study
    Klajda, Michael D.
    Scott, Christopher G.
    Rodeheffer, Richard J.
    Chen, Horng H.
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 124 - 133